Last edition
News about
GV20 Therapeutics Hits Milestone in ADC Collaboration with Mitsubishi Tanabe Pharma
GV20 Therapeutics has secured a milestone payment from Mitsubishi Tanabe Pharma under their 2025 collaboration to develop the first-in-class Antibody Drug Conjugates (ADCs) using GV20’s STEAD AI–discovered tumour-targeting antibodies.
Exyte Completes Pharmaplan's Integration
The completed integration of Pharmaplan marks a major milestone in Exyte’s strategy to build a leading European player in life sciences engineering and strengthen collaboration with the region’s biotechnology and pharmaceutical industries.
Cytiva and Veeda Lifesciences Launch New HCP Services Centre
The collaboration between Cytiva and Veeda Lifesciences brings a dedicated Host Cell Protein (HCP) services centre offering comprehensive HCP coverage, characterization, and quantification assays, enabling global biopharma companies to enhance the safety, efficacy, and quality of their biologics development
Himalaya Wellness Partners with Unicommerce to Boost Omnichannel Growth
Himalaya Wellness, one of India’s most trusted legacy wellness brands, has partnered with Unicommerce, a leading e-commerce enablement SaaS platform, to streamline its digital operations and accelerate its omnichannel transformation.
FDA Grants Priority Review to Sonrotoclax to Treat Relapsed/Refractory Mantle Cell Lymphoma
The priority review positions sonrotoclax to potentially become the first BCL2 inhibitor approved in the U.S. for relapsed or refractory mantle cell lymphoma, offering a promising new option for patients with this aggressive and hard-to-treat cancer.
Crane NXT to Acquire Antares Vision, Plans Take-Private Deal
Crane NXT, a leading industrial technology company, announced that it has signed definitive agreements to acquire a significant stake in Antares Vision S.p.A., with plans to take the company private.
TempraMed Technologies Inks Distribution Agreement with Guri
The partnership marks TempraMed’s entry into a broader global rollout, with the Guri agreement serving as the first step in a series of regional distribution deals planned across Europe, the Middle East, North America, and Asia.
India and Switzerland Explore Pharma-Biotech Collaboration After High-Level Meeting
The talks emphasised avenues for Swiss companies to invest in India’s pharma and biotech industries and to leverage the country’s robust healthcare market.
Valneva to Further Consolidate its Operations in France
The move is part of Valneva’s strategy to optimise its global footprint, enhance operational efficiency in France, and unify all research and development efforts at its Vienna hub.
Glenmark Pharmaceuticals Receives EIR from US FDA for Monroe Facility
Glenmark Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US FDA for its formulations manufacturing facility in Monroe, with a Voluntary Action Indicated (VAI) status.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy